215 related articles for article (PubMed ID: 12740452)
1. Metabolic adaptations to dexamethasone-induced insulin resistance in healthy volunteers.
Nicod N; Giusti V; Besse C; Tappy L
Obes Res; 2003 May; 11(5):625-31. PubMed ID: 12740452
[TBL] [Abstract][Full Text] [Related]
2. Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses.
Tiley HA; Geor RJ; McCutcheon LJ
Am J Vet Res; 2007 Jul; 68(7):753-9. PubMed ID: 17605611
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
[TBL] [Abstract][Full Text] [Related]
4. Effects of colostrum feeding and glucocorticoid administration on insulin-dependent glucose metabolism in neonatal calves.
Scheuer BH; Zbinden Y; Schneiter P; Tappy L; Blum JW; Hammon HM
Domest Anim Endocrinol; 2006 Oct; 31(3):227-45. PubMed ID: 16360295
[TBL] [Abstract][Full Text] [Related]
5. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
6. Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects.
Abdul-Ghani MA; Matsuda M; DeFronzo RA
Diabet Med; 2008 Nov; 25(11):1289-94. PubMed ID: 19046218
[TBL] [Abstract][Full Text] [Related]
7. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
8. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
9. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
[TBL] [Abstract][Full Text] [Related]
10. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
11. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
[TBL] [Abstract][Full Text] [Related]
12. Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.
Corporeau C; Foll CL; Taouis M; Gouygou JP; Bergé JP; Delarue J
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E78-E86. PubMed ID: 16339925
[TBL] [Abstract][Full Text] [Related]
13. Glucose homeostasis in Huntington disease: abnormalities in insulin sensitivity and early-phase insulin secretion.
Lalić NM; Marić J; Svetel M; Jotić A; Stefanova E; Lalić K; Dragasević N; Milicić T; Lukić L; Kostić VS
Arch Neurol; 2008 Apr; 65(4):476-80. PubMed ID: 18413469
[TBL] [Abstract][Full Text] [Related]
14. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
15. Effect of a single dose of dexamethasone on glucose homeostasis in healthy horses by using the combined intravenous glucose and insulin test.
Haffner JC; Eiler H; Hoffman RM; Fecteau KA; Oliver JW
J Anim Sci; 2009 Jan; 87(1):131-5. PubMed ID: 18820160
[TBL] [Abstract][Full Text] [Related]
16. Peripheral insulin sensitivity is decreased by elevated non-esterified fatty acid level in dexamethasone-treated rats.
Mokuda O; Sakamoto Y
Diabetes Nutr Metab; 1999 Aug; 12(4):252-5. PubMed ID: 10782750
[TBL] [Abstract][Full Text] [Related]
17. Impaired beta-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome.
Ehrmann DA; Breda E; Corcoran MC; Cavaghan MK; Imperial J; Toffolo G; Cobelli C; Polonsky KS
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E241-6. PubMed ID: 14665448
[TBL] [Abstract][Full Text] [Related]
18. Relationship between visceral adiposity and intramyocellular lipid content in two rat models of insulin resistance.
Korach-André M; Gao J; Gounarides JS; Deacon R; Islam A; Laurent D
Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E106-16. PubMed ID: 15328072
[TBL] [Abstract][Full Text] [Related]
19. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V
Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144
[TBL] [Abstract][Full Text] [Related]
20. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Bock G; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Chandramouli V; Landau BR; Rizza RA
Diabetes; 2007 Jun; 56(6):1703-11. PubMed ID: 17384334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
